Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment

Glioblastoma (GBM) is the most aggressive among the neurological tumors. At present, no chemotherapy or radiotherapy regimen is associated with a positive long-term outcome. In the majority of cases, the tumor recurs within 32–36 weeks of initial treatment. The recent discovery that Zika virus (ZIKV...

Descripción completa

Detalles Bibliográficos
Autores principales: Francipane, Maria Giovanna, Douradinha, Bruno, Chinnici, Cinzia Maria, Russelli, Giovanna, Conaldi, Pier Giulio, Iannolo, Gioacchin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537796/
https://www.ncbi.nlm.nih.gov/pubmed/34681654
http://dx.doi.org/10.3390/ijms222010996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537796/
https://www.ncbi.nlm.nih.gov/pubmed/34681654
http://dx.doi.org/10.3390/ijms222010996

Ejemplares similares